BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11369740)

  • 1. Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China.
    Lacey JV; Deng J; Dosemeci M; Gao YT; Mostofi FK; Sesterhenn IA; Xie T; Hsing AW
    Int J Epidemiol; 2001 Apr; 30(2):341-9. PubMed ID: 11369740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
    Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
    Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
    Madigan MP; Gao YT; Deng J; Pfeiffer RM; Chang BL; Zheng S; Meyers DA; Stanczyk FZ; Xu J; Hsing AW
    Int J Cancer; 2003 Nov; 107(2):271-5. PubMed ID: 12949806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiologic correlations of prostate cancer in Guangdong, China to family history of cancers, and sexual and marital factors-a case-control study].
    Liang CH; Liu Q; Zhou FJ; Gao X; Chen LW
    Ai Zheng; 2007 May; 26(5):484-8. PubMed ID: 17672937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime occupational physical activity and incidental prostate cancer (Canada).
    Bairati I; Larouche R; Meyer F; Moore L; Fradet Y
    Cancer Causes Control; 2000 Sep; 11(8):759-64. PubMed ID: 11065013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia.
    Fritschi L; Glass DC; Tabrizi JS; Leavy JE; Ambrosini GL
    Occup Environ Med; 2007 Jan; 64(1):60-5. PubMed ID: 17018583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate physical activity and prostate cancer risk: a case-control study in China.
    Jian L; Shen ZJ; Lee AH; Binns CW
    Eur J Epidemiol; 2005; 20(2):155-60. PubMed ID: 15792282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupation, physical activity, and risk of prostate cancer in Shanghai, People's Republic of China.
    Hsing AW; McLaughlin JK; Zheng W; Gao YT; Blot WJ
    Cancer Causes Control; 1994 Mar; 5(2):136-40. PubMed ID: 8167260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
    Boehm K; Valdivieso R; Meskawi M; Larcher A; Sun M; Sosa J; Blanc-Lapierre A; Weiss D; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
    World J Urol; 2015 Dec; 33(12):2063-9. PubMed ID: 25824539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of lifetime total physical activity and prostate cancer risk.
    Friedenreich CM; McGregor SE; Courneya KS; Angyalfi SJ; Elliott FG
    Am J Epidemiol; 2004 Apr; 159(8):740-9. PubMed ID: 15051583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of physical activity and prostate cancer in male health professionals.
    Giovannucci E; Leitzmann M; Spiegelman D; Rimm EB; Colditz GA; Stampfer MJ; Willett WC
    Cancer Res; 1998 Nov; 58(22):5117-22. PubMed ID: 9823321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China.
    Gu FL; Xia TL; Kong XT
    Urology; 1994 Nov; 44(5):688-91. PubMed ID: 7526525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk.
    Hung SC; Lai SW; Tsai PY; Chen PC; Wu HC; Lin WH; Sung FC
    Br J Cancer; 2013 May; 108(9):1778-83. PubMed ID: 23612451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
    Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
    Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China.
    Gu F
    Chin Med J (Engl); 2000 Apr; 113(4):299-302. PubMed ID: 11775222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime recreational physical activity and the risk of prostate cancer.
    Sorial E; Si S; Fritschi L; Darcey E; Leavy JE; Girschik J; Ambrosini GL; Boyle T
    Cancer Causes Control; 2019 Jun; 30(6):617-625. PubMed ID: 30963392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study.
    Kuo YJ; Sung FC; Hsieh PF; Chang HP; Wu KL; Wu HC
    Cancer Med; 2019 May; 8(5):2514-2523. PubMed ID: 30968600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.